| 注册
首页|期刊导航|中国药理学通报|桥粒芯糖蛋白表达和功能异常相关疾病及药物干预作用研究进展

桥粒芯糖蛋白表达和功能异常相关疾病及药物干预作用研究进展

张译丹 尹清晟 耿诗涵 许梦习 庄朋伟 张艳军

中国药理学通报2017,Vol.33Issue(11):1485-1489,5.
中国药理学通报2017,Vol.33Issue(11):1485-1489,5.DOI:10.3969/j.issn.1001-1978.2017.11.002

桥粒芯糖蛋白表达和功能异常相关疾病及药物干预作用研究进展

Progression of related diseases of desmoglein abnormal and pharmacological intervention

张译丹 1尹清晟 1耿诗涵 1许梦习 1庄朋伟 1张艳军1

作者信息

  • 1. 天津中医药大学中药药理学重点实验室,天津300193
  • 折叠

摘要

Abstract

Desmoglein,which is a kind of Ca2+ dependent desmosomal cadherins protein,is a major part of the desmosomes.The desmoglein that distributes in the epithelium,myocardium and other tissues plays a very important role in the cell junction.In recent years,the detection of the abnormal expression and function of the desmoglein was proved in many diseases,such as skin,mucous membrane and tumor related diseases.Drugs may have an important effect in the treatment of diseases by interfering with the expression and function of desmoglein.In this paper,the distribution of several subtypes of the family of desmosomes and their functions in the related diseases are reviewed,which may also provide some new clues for the new drug research on the target of desmogleins.

关键词

桥粒芯糖蛋白/分布/皮肤疾病/黏膜疾病/肿瘤/药物干预

Key words

desmoglein/distribution/skin tissue diseases/disease of mucosa/neoplasms/pharmacological intervention

分类

医药卫生

引用本文复制引用

张译丹,尹清晟,耿诗涵,许梦习,庄朋伟,张艳军..桥粒芯糖蛋白表达和功能异常相关疾病及药物干预作用研究进展[J].中国药理学通报,2017,33(11):1485-1489,5.

基金项目

长江学者和创新团队发展计划资助项目(No IRT_14R41) (No IRT_14R41)

中国药理学通报

OA北大核心CSCDCSTPCD

1001-1978

访问量1
|
下载量0
段落导航相关论文